Companion Diagnostics Market PPT 2022: Size, Growth, Demand and Forecast till 2027

Author: Elena Anderson

Marketing Manager

Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Companion Diagnostics Market Research Report 2022-2027:

According to the latest report by IMARC Group, titled " Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Fore cast 2022-2027

," the global companion diagnostics market size reached US$ 5.0 Billion in 2021.

Companion diagnostic is an in-vitro diagnostic testing kit, consisting of a combination of tests and therapies that are used for the development of personalized medicines. It is used to determine the personal molecular profile of patients that aids healthcare professionals in deciding upon the approach for their treatment. It also offers information regarding the safe and effective use of a certain corresponding drug or biological product.

Its usage assists in delivering safe and effective medical care to patients by analyzing the responders and non-responders to the therapy and offering an in-depth understanding of the biology of their disease. Currently, these kits are widely used in oncology for drug discovery and delivering targeted therapies to individuals.

Request for a PDF sample of this report:

https://www.imarcgroup.com/companion-diagnostics-market/requestsample

Global Companion Diagnostics Market Trends:

The market is primarily driven by the increasing incidences of various forms of cancer on the global level. Companion diagnostics are widely used in advanced oncology healthcare for targeting biomarker identification and delivering targeted therapies to patients, thereby providing a thrust to the market growth. There has also been a significant increase in the demand for in-vitro diagnostics among the masses. This, along with the growing preference for personalized healthcare (PHC) and precision medicine in the healthcare sector, is facilitating the uptake of these diagnostics. Apart from this, there has been a rise in the utilization of targeted drugs and therapies for treating several infectious, cardiovascular, neurological, and inflammatory conditions. Coupled with the development of nextgeneration sequencing (NGS) and the increasing number of clinical trials, this is creating a positive outlook for the market.

Additionally, several regulatory bodies, such as the US Food and Drug Administration (US FDA), have provided a defined structure for companion diagnostic development while encouraging the market players to conduct research activities in this field. The continual launch of new biomarkers, as well as the increasing number of collaborations between two or more companies for developing novel companion diagnostic products, is also providing an impetus to the market growth.

Report Description Report Description and Highlights

Looking forward, IMARC Group expects the market is anticipated to grow at a CAGR of 14.78% during 2022-2027. View Report TOC, Figures and Tables: https://www.imarcgroup.com/companion-diagnostics-market

Report Description Report Description and Highlights

Key Market Segmentation

The research report includes the following segments:

Breakup by Product & Service:

• Assays, Kits and Reagents

• Software and Services

Breakup by Technology:

• Immunohistochemistry (IHC)

• Polymerase Chain Reaction (PCR)

• In-situ Hybridization (ISH)

• Real-time PCR (RT-PCR)

• Gene Sequencing

• Others

Breakup by Indication:

• Cancer

o Lung Cancer

o Breast Cancer

o Colorectal Cancer

o Gastric Cancer

o Melanoma

o Others

• Neurological Diseases

• Infectious Diseases

• Cardiovascular Diseases

• Others

Breakup by End User:

• Pharmaceutical & Biopharmaceutical Companies

• Reference Laboratories

• Contract Research Organizations

• Others

Breakup by Region:

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East and Africa

Report Description Report Description and Highlights

Competitive Landscape with Key Players:

• Abbott Laboratories

• Agilent Technologies

• BioMerieux

• Danaher Corporation

• Roche Holding AG

• Myriad Genetics Inc

• Siemens Healthcare

• Thermo Fisher Scientific Inc

1. What was the size of the global companion diagnostics market in 2021?

2. What is the expected growth rate of the global companion diagnostics market during 20222027?

3. What has been the impact of COVID-19 on the global companion diagnostics market?

4. What are the key factors driving the global companion diagnostics market?

5. What is the breakup of the global companion diagnostics market based on the product & service?

6. What is the breakup of the global companion diagnostics market based on the technology?

7. What is the breakup of the global companion diagnostics market based on the indication?

8. What is the breakup of the global companion diagnostics market based on the end user?

9. What are the key regions in the global companion diagnostics market?

10. Who are the key players/companies in the global companion diagnostics market?

Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/companion-diagnostics-market/toc

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2022 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.